Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | H1₹41.58Admitted-Finance PLOT NO 2117 A 2 PHASE II II G I D C VAPI GUJARAT INDIA 396195 | VAPI | VALSAD | GUJARAT | 396195 | H1 | Admitted-Finance | |
| 2 | H2₹38.69−₹2.89 (6.95%)Admitted-Finance | H2 | Admitted-Finance | |
| 3 | H3₹32.94−₹8.64 (20.8%)Admitted-Finance C 21 22 23 SECTOR 3 NOIDA GB NAGAR UP UNICURE INDIA LTD NOIDA SECTOR 3 GAUTAM BUDH NAGAR GAUTAM BUDDHA NAGAR UTTAR PRADESH 201301 | GAUTAM BUDDHA NAGAR | UTTAR PRADESH | 201301 | H3 | Admitted-Finance | |
| 4 | H4₹31.66−₹9.92 (23.9%)Admitted-Finance SURVEY NO 144 A JAROD SAMLAYA ROAD VILL HARIPURA TAL SAVLI DIST VADODARA GUJARAT INDIA 391520 | VADODARA | VADODARA | GUJARAT | 391520 | H4 | Admitted-Finance | |
| 5 | H5₹23.08−₹18.50 (44.5%)Admitted-Finance | H5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | MYLAN LABORATORIES LIMITED H7 | MICRON PHARMACEUTICALS H1 | UNICURE INDIA LIMITED H3 | Hetero Healthcare Limited H2 | Bharat Parenterals Ltd. H4 | EMCURE PHARMACEUTICALS LTD. H5 | Macleods Pharmaceuticals Ltd. H6 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.00ARV DRUGS | ||||||||||
| 1.01 | Darunavir 600mg
(Regular Tender Schedule) | 1,09,17,120 | Tablet | - | 29.7 ₹31.18 | 22.78 ₹23.92 | 26.45 ₹27.77 | 21.33 ₹22.4 Lowest | 21.98 ₹23.08 | - |
| 1.02 | Ritonavir 100mg
(Regular Tender Schedule) | 1,10,27,160 | Tablet | - | 3.96 ₹4.16 | 3.75 ₹3.94 | 4.7 ₹4.94 | 3.42 ₹3.59 Lowest | - | - |
| 1.03 | Dolutegravir 10mg
(Regular Tender Schedule) | 2,70,00,000 | Tablet | 1.77 ₹1.86 Lowest | - | - | - | - | - | 2.23 ₹2.34 |
| 1.04 | Tenofovir 300mg +
Lamivudine 300mg (TL)
(Regular Tender Schedule) | 20,88,000 | Tablet | - | 5.94 ₹6.24 | 4.84 ₹5.08 Lowest | 5.7 ₹5.99 | 5.4 ₹5.67 | - | - |
| 1.05 | Dolutegravir 10mg
(Developmental Tender Schedule) | 67,50,000 | Tablet | - | - | - | - | - | - | 2.77 ₹2.91 Lowest |
Tender Value
Refer Docs
EMD Value
₹1.5 Cr
Closing Date
29 Sept 2025, 3:00 pmClosed
DG AND CEO, CMSS
CMSS, New Delhi
TENDER FOR RATE CONTRACT for procurement of 4 number of ARV drugs namely Darunavir 600mg Ritonavir 100mg Dolutegravir 10mg and Tenofovir 300mg with Lamivudine 300mg
2025_CMSS_874496_1
CMSS/PROC/2025-26/NACO/023
Open Tender
Drugs and Pharmaceutical Products
Supply
90 days
CMSS HQ New Delhi
As per Tender Document
3 documents required · 3 mandatory
₹0
₹1.5 Cr
Yes
CMSS, HQ New Delhi
10 Nov 2025
23 Aug 2025
30 Sept 2025
23 Aug 2025
29 Sept 2025
24 Aug 2025
23 Aug 2025 - 29 Aug 2025
29 Aug 2025
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1ARV DRUGS | |||||
| 1.01 | Darunavir 600mg
(Regular Tender Schedule) | 1,09,17,120 | Tablet | - | - |
| 1.02 | Ritonavir 100mg
(Regular Tender Schedule) | 1,10,27,160 | Tablet | - | - |
| 1.03 | Dolutegravir 10mg
(Regular Tender Schedule) | 2,70,00,000 | Tablet | - | - |
| 1.04 | Tenofovir 300mg +
Lamivudine 300mg (TL)
(Regular Tender Schedule) | 20,88,000 | Tablet | - | - |
| 1.05 | Dolutegravir 10mg
(Developmental Tender Schedule) | 67,50,000 | Tablet | - | - |
stage.html
html • 0.04 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.26 MB
BOQ_919264.xls
BOQ • 0.31 MB
TED_023.pdf
PDF • 2.96 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .